Trump Administration Pushes Rule to Expand Fertility Benefits, But Watch for the Fine Print

The Trump administration announced a proposed rule designed to expand access to fertility benefits for American workers by creating a new legal category called “limited excepted benefits.” This rule, spearheaded by the Departments of Labor, Health and Human Services, and Treasury, aims to ease regulatory barriers so employers can offer fertility treatments like in vitro fertilization (IVF) more broadly.

Acting Labor Secretary Keith Sonderling framed the move as fulfilling President Trump’s promise to support family formation and stability, calling it a step toward “delivering on our promises to the American worker and their families.” HHS Secretary Robert F. Kennedy Jr. echoed this, highlighting the administration’s concern over declining birth rates and positioning the rule as a pathway to “starting and growing families.”

The proposal sets some guardrails: benefits must focus primarily on infertility diagnosis and treatment, with a combined lifetime cap of $120,000 per participant and their dependents — a figure that will adjust with inflation after 2028. Employers must also provide clear notices explaining the coverage.

At first glance, expanding fertility coverage sounds like a positive development. Most Americans of reproductive age get their health insurance through employers, yet many face limited or no fertility benefits. This rule could lower costs and increase options for those seeking fertility care.

But here’s the catch: by creating a new “limited excepted benefits” category, these fertility benefits would largely be exempt from the Affordable Care Act’s market reforms and consumer protections. Excepted benefits typically enjoy fewer regulations around coverage standards, consumer rights, and nondiscrimination rules. This raises concerns about whether the benefits will be comprehensive or affordable in practice, and whether they might undermine broader health coverage.

This move fits a broader pattern from the Trump administration of using regulatory changes to bypass Congress and weaken established health protections under the guise of expanding choice. While touted as a family-friendly policy, it’s essential to scrutinize how this rule might shift costs or limit access in ways that ultimately serve employer interests more than workers.

The administration is now taking public comments for 60 days. Given the stakes—fertility care is already expensive and unevenly covered—advocates and workers should weigh in to demand transparency, fairness, and real access rather than narrow benefits that sidestep consumer protections.

In the end, expanding fertility benefits sounds good on paper, but the devil is in the details. This rule is another example of the Trump administration’s approach: bold promises wrapped in regulatory maneuvers that may erode protections while claiming to help families. We’ll be watching closely to see who wins and who loses as this unfolds.